Factors | Number | Univariate | Multivariate | ||
---|---|---|---|---|---|
HR(95%CI) | P | HR(95%CI) | P | ||
Pathological N stage | Â | Â | <0.001 | Â | <0.001 |
 pN0 | 106 | 1 |  | 1 |  |
 pN+ | 87 | 1.984(1.438–2.737) |  | 0.507(0.360–0.714) |  |
Pathological TNM stage |  |  | <0.001 | – | – |
 I/II | 116 | 1 |  |  |  |
 III | 77 | 2.353(1.697–3.263) |  |  |  |
Salvage treatment | Â | Â | <0.001 | Â | <0.001 |
 SCRT | 48 | 1 |  | 1 |  |
 SRT | 109 | 1.510(1.002–2.276) | 0.049 | 1.419(0.940–2.142) | 0.096 |
 No RT | 36 | 4.175(2.529–6.891) | <0.001 | 3.246(1.931–5.458) | <0.001 |
Site of recurrence |  |  | 0.002 | – | – |
 Above the diaphragm | 139 | 1 |  |  |  |
 Along with upper abdominal LN recurrence | 24 | 1.967(1.234–3.136) | 0.004 |  |  |
 Along with hematogenous metastases | 30 | 1.816(1.177–2.804) | 0.007 |  |  |
Number of LN recurrence regions |  |  | 0.042 | – | – |
 Single region | 83 | 1 |  |  |  |
 Multiple regions | 110 | 1.408(1.012–1.958) |  |  |  |